Zobrazeno 1 - 10
of 35 369
pro vyhledávání: '"Paroxysmal Nocturnal Hemoglobinuria"'
Publikováno v:
Chinese Journal of Stroke. Jun2024, Vol. 19 Issue 6, p699-705. 7p.
Autor:
CHEN Miao, YANG Chen, LIU Ziwei, CAO Wei, ZHANG Bo, LIU Xin, LI Jingnan, LIU Wei, PAN Jie, WANG Jian, ZHENG Yuehong, CHEN Yuexin, LI Fangda, DU Shunda, NING Cong, CHEN Limeng, YUE Cai, NI Jun, PENG Min, GUO Xiaoxiao, WANG Tao, LI Hongjun, LI Rongrong, WU Tong, HAN Bing, ZHANG Shuyang, Multidiscipline Collaboration Group on Rare Disease at Peking Union Medical College Hospital
Publikováno v:
Xiehe Yixue Zazhi, Vol 15, Iss 5, Pp 1011-1028 (2024)
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal hematopoietic stem cell disease caused by abnormal expression of glycosylphosphatidylinositol (GPI) on the cell membrane due to mutations in the phosphatidylinositol glycan class A(PIGA)
Externí odkaz:
https://doaj.org/article/c7dcc3d643aa474eac91a43434975641
Autor:
Horneff, Regina1 (AUTHOR) regina.horneff@sobi.com, Czech, Barbara1 (AUTHOR), Yeh, Michael2 (AUTHOR), Surova, Elena1 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p8698. 16p.
Autor:
M. V. Marchenko, O. U. Klimova, E. V. Anikina, A. V. Lapina, T. A. Rudakova, T. I. Ksenzova, A. D. Kulagin
Publikováno v:
Онкогематология, Vol 19, Iss 3, Pp 68-78 (2024)
The introduction of the complement component C5 inhibitor eculizumab has radically changed the prognosis and quality of life of patients with paroxysmal nocturnal hemoglobinuria. Up to 30 % of patients develop only a suboptimal response to C5 inhibit
Externí odkaz:
https://doaj.org/article/71420cfe4cba44df9b8161e886d0f53e
Publikováno v:
Journal of Nippon Medical School. 2024, Vol. 91 Issue 5, p512-517. 6p.
Autor:
Sakurai, Kazuki1,2 (AUTHOR) kzk.sakurai.2212@gmail.com, Saito, Kei1 (AUTHOR), Hatta, Shunsuke1 (AUTHOR), Katsuoka, Yuna1 (AUTHOR), Meguro, Kuniaki1 (AUTHOR), Yokoyama, Hisayuki1,2 (AUTHOR), Izumi, Toru1 (AUTHOR)
Publikováno v:
Clinical Case Reports. May2024, Vol. 12 Issue 5, p1-5. 5p.
Autor:
Ilic, Jovanka1 (AUTHOR), Pujic, Borislava2 (AUTHOR), Jakovljevic, Branislava3 (AUTHOR), Sekulic, Borivoj1,4 (AUTHOR), Agic, Danijela1,4 (AUTHOR), El Farra, Amir1,4 (AUTHOR), Micanovic, Branimir1 (AUTHOR), Vejnovic, Tihomir3,5 (AUTHOR), Urosevic, Ivana1,4 (AUTHOR), Savic, Aleksandar1,4 (AUTHOR) aleksandar.savic@mf.uns.ac.rs
Publikováno v:
Clinical Case Reports. May2024, Vol. 12 Issue 5, p1-6. 6p.
Autor:
Griffiths, Elizabeth A.1 (AUTHOR), Min, Jae S.2 (AUTHOR), Lee, Wei-Nchih2 (AUTHOR), Yu, Jeffrey C.3 (AUTHOR), Patel, Yogesh3 (AUTHOR), Myren, Karl-Johan4 (AUTHOR), Dingli, David5 (AUTHOR) Dingli.David@mayo.edu
Publikováno v:
Health & Quality of Life Outcomes. 8/9/2024, Vol. 22 Issue 1, p1-9. 9p.
Autor:
Bicskó, Ráhel Réka1 (AUTHOR) bicsko.reka@med.unideb.hu, Illés, Árpád1 (AUTHOR) lgergely@med.unideb.hu, Hevessy, Zsuzsanna2 (AUTHOR) hevessy@med.unideb.hu, Ivády, Gergely2 (AUTHOR) ivady@med.unideb.hu, Kerekes, György3 (AUTHOR) gkerekes@med.unideb.hu, Méhes, Gábor4 (AUTHOR) gabor.mehes@med.unideb.hu, Csépány, Tünde5 (AUTHOR) csepany@med.unideb.hu, Gergely, Lajos1 (AUTHOR)
Publikováno v:
Hematology Reports. Jun2024, Vol. 16 Issue 2, p255-259. 5p.